CRC
RCEL icon

Curi RMB Capital’s Avita Medical RCEL Stock Holding History

Curi RMB Capital’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,281
Closed -$42.4K – 938
2025
Q4 		$42.4K Sell
12,281
-6,666
-35% -$26.6K ﹤0.01% 871
2025
Q3 		$96.8K Hold
18,947
– – ﹤0.01% 699
2025
Q2 		$100K Buy
+18,947
New +$138K ﹤0.01% 659
2025
Q1 		– Sell
-23,000
Closed -$294K – 534
2024
Q4 		$294K Sell
23,000
-20,025
-47% -$236K 0.01% 463
2024
Q3 		$461K Hold
43,025
– – 0.01% 430
2024
Q2 		$341K Hold
43,025
– – 0.01% 458
2024
Q1 		$690K Buy
43,025
+30,025
+231% +$486K 0.02% 392
2023
Q4 		$178K Buy
+13,000
New +$149K 0.01% 498

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Curi RMB Capital's RCEL Position: Q1 2026 in Review

Curi RMB Capital sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 12,281 shares — an estimated $42.4K sold.

Curi RMB Capital first reported a position in RCEL in Q4 2023 and held it in 8 quarters. The position peaked at $690K in Q1 2024. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Curi RMB Capital reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • Curi RMB Capital sold 12,281 Avita Medical shares in Q1 2026, an estimated $42.4K.
  • Curi RMB Capital first reported a position in Avita Medical in Q4 2023 and held it in 8 quarters.
  • Curi RMB Capital's Avita Medical position peaked at $690K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.